21:15 21 October 2021
AstraZeneca to stay longer at Postępu 14 office building in Warsaw
CA Immo has signed a lease extension agreement in the Warsaw office building Postępu 14. AstraZeneca Pharma Poland has decided to stay in the building for another five years and lease an additional 3,000 sqm of the modern workspace. Consequently, the seat of AstraZeneca Pharma Poland in Warsaw will amount to ca. 21,000 sqm, which represents more than 60 percent of the building’s entire area.
“This agreement was concluded less than a year after we purchased the building in 2020, which confirms our investment decision. The Postępu 14 office building is a great asset in terms of quality and location, meeting the expectations of well-known, international companies. I would like to thank the Management Team of AstraZeneca for their trust and we look forward to furthering fruitful cooperation,” Andrzej Mikołajczyk, Managing Director at CA Immo Poland, said.
AstraZeneca is one of the largest global biopharmaceutical companies, providing cutting-edge medicines for the diseases facing modern medicine. It has been present in Poland for 30 years and employs nearly 2,300 people locally. The Warsaw branch of the company, which has been operating in the Postępu 14 building since 2016, is significantly expanding again.
(WBJ)
